Advertisement

Neurocritical Care

, Volume 30, Issue 2, pp 355–363 | Cite as

Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?

  • K. M. SauroEmail author
  • A. Soo
  • A. Kramer
  • P. Couillard
  • J. Kromm
  • D. Zygun
  • D. J. Niven
  • S. M. Bagshaw
  • H. T. Stelfox
Original Article

Abstract

Background/Objectives

Venous thromboembolism (VTE) is a leading cause of preventable, in-hospital deaths; critically ill patients have a higher risk. Effective and efficient strategies to prevent VTE exist; however, neurocritical care patients present unique challenges due to competing risk of bleeding. The objective of this study was to examine current VTE prophylaxis practices among neurocritical care patients, concordance with guideline-recommended care, and the association with clinical outcomes.

Methods

This retrospective cohort study of patients admitted to ten adult, medical–surgical and neurological intensive care units (ICUs) in nine hospitals between 2014 and 2017 using administrative and clinical data. Neurocritical care patients were classified based on the primary admission diagnosis. Concordance with guideline-recommended care was evaluated using recommendations from recent guidelines.

Results

20.0% of 23,191 patients were classified as neurocritical care. Among neurocritical care patients, pharmacological VTE prophylaxis was administered on 60.9% of all ICU days, mechanical VTE prophylaxis on 46.9%, and no VTE prophylaxis on 12.2% of all ICU days. Type of VTE prophylaxis was associated with sex, neurological diagnosis, and invasive neurological monitoring. Fifty-six percentage of ICU days were guideline concordant but concordance varied by recommendation (range 6–100%) and by type of VTE prophylaxis recommended (p = 0.05); among patients where guidelines recommended use of pharmacologic prophylaxis, care was concordant 26.6% of ICU days, whereas for mechanical prophylaxis it was concordant 80.5% of ICU days. There was an overall improvement in guideline concordance on 2.3% of ICU days after the publication of the Society of Neurocritical Care guideline (p = 0.005).

Conclusions

Neurocritical care patients commonly receive mechanical VTE prophylaxis despite guidelines recommending the use of pharmacological VTE prophylaxis. Our findings suggest uncertainty around best VTE prophylaxis practices for neurocritical care patients remains.

Keywords

Practice guidelines Evidence-based medicine Clinical audit Quality of health care VTE 

Notes

Acknowledgements

K. M. Sauro has received a postdoctoral fellowship from the Canadian Institute for Health Research, Ward of the 21st Century and O’Brien Institute for Public Health (Cumming School of Medicine, University of Calgary). S. M. Bagshaw is supported by a Canada Research Chair in Critical Care Nephrology. H. T. Stelfox is supported by an Embedded Clinician Research Award from the Canadian Institutes of Health Research.

Authors’ contributions

KMS contributed to the design and conceptualization of the study, analysis and interpretation of the data, and drafting and revising the manuscript and gave approval of the final version of the manuscript; AS contributed to the analysis and interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; AK contributed to the interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; PC contributed to the interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; JK contributed to the interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; DZ contributed to the interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; DJN contributed to the interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; SMB contributed to the interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript; HTS contributed to the design and conceptualization of the study, interpretation of the data, providing feedback on the manuscript, and gave approval of the final version of the manuscript.

Source of support

There was no financial support provided for this project.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Supplementary material

12028_2018_614_MOESM1_ESM.docx (38 kb)
Supplementary material 1 (DOCX 37 kb)

References

  1. 1.
    Blann AD, Lip GY. Venous thromboembolism. BMJ (Clin Res Ed). 2006;332:215–9.CrossRefGoogle Scholar
  2. 2.
    Heit JA, Melton LJ 3rd, Lohse CM, et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc. 2001;76:1102–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161:1268–79.CrossRefPubMedGoogle Scholar
  4. 4.
    Patel R, Cook DJ, Meade MO, et al. Burden of illness in venous thromboembolism in critical care: a multicenter observational study. J Crit Care. 2005;20:341–7.CrossRefPubMedGoogle Scholar
  5. 5.
    White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:I4–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol. 2011;86:217–20.CrossRefPubMedGoogle Scholar
  7. 7.
    Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756–64.CrossRefPubMedGoogle Scholar
  8. 8.
    Nyquist P, Bautista C, Jichici D, et al. Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the neurocritical care society. Neurocrit Care. 2016;24:47–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Indredavik B, Rohweder G, Naalsund E, Lydersen S. Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke J Cereb Circ. 2008;39:414–20.CrossRefGoogle Scholar
  10. 10.
    Gearhart MM, Luchette FA, Proctor MC, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery. 2000;128:631–40.CrossRefPubMedGoogle Scholar
  11. 11.
    American College of Surgeons Trauma Quality Improvement Program. Best practices in the managment of traumatic brain injury; 2015.Google Scholar
  12. 12.
    Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80:6–15.PubMedGoogle Scholar
  13. 13.
    Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke J Cereb Circ. 2015;46:2032–60.CrossRefGoogle Scholar
  14. 14.
    Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke J Cereb Circ. 2013;44:870–947.CrossRefGoogle Scholar
  15. 15.
    Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and Thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141:e601S–36S.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Stelfox HT, Leigh JP, Dodek PM, et al. A multi-center prospective cohort study of patient transfers from the intensive care unit to the hospital ward. Intensive Care Med. 2017;43:1485–94.CrossRefPubMedGoogle Scholar
  17. 17.
    Brundin-Mather R, Soo A, Zuege DJ, et al. Secondary EMR data for quality improvement and research: a comparison of manual and electronic data collection from an integrated critical care electronic medical record system. J Crit Care. 2018;47:295–301.  https://doi.org/10.1016/j.jcrc.2018.07.021.CrossRefPubMedGoogle Scholar
  18. 18.
    Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. The validity of ICD codes coupled with imaging procedure codes for identifying acute venous thromboembolism using administrative data. Vasc Med. 2015;20:364–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Arnold DM, Donahoe L, Clarke FJ, et al. Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med. 2007;30:E93–102.CrossRefPubMedGoogle Scholar
  20. 20.
    Al-Ani F, Shariff S, Siqueira L, Seyam A, Lazo-Langner A. Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data. Thromb Res. 2015;136:1195–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Fang MC, Fan D, Sung SH, et al. Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE Study. Med Care. 2016;55:e137–43.CrossRefGoogle Scholar
  22. 22.
    Sanfilippo KM, Wang TF, Gage BF, Liu W, Carson KR. Improving accuracy of international classification of diseases codes for venous thromboembolism in administrative data. Thromb Res. 2015;135:616–20.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet (London, England). 1993;342:1317–22.CrossRefGoogle Scholar
  24. 24.
    Micieli G, Cavallini A, Quaglini S. Guideline compliance improves stroke outcome: a preliminary study in 4 districts in the Italian region of Lombardia. Stroke J Cereb Circ. 2002;33:1341–7.CrossRefGoogle Scholar
  25. 25.
    Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104:510–20.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65.CrossRefPubMedGoogle Scholar
  27. 27.
    Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8:38.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Graham ID, Logan J, Harrison MB, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26:13–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Wensing M, van der Weijden T, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract. 1998;48:991–7.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Fowler RA, Mittmann N, Geerts W, et al. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA. 2014;312:2135–45.CrossRefPubMedGoogle Scholar
  31. 31.
    PROTECT collaborators. Dalteparin versus unfractionated heparin in critically Ill patients. N Engl J Med. 2011;364:1305–14.CrossRefGoogle Scholar
  32. 32.
    Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013;41:2088–98.CrossRefPubMedGoogle Scholar
  33. 33.
    Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486–552.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2018

Authors and Affiliations

  1. 1.Department of Critical Care MedicineUniversity of CalgaryCalgaryCanada
  2. 2.Department of Community Health Science, O’Brien Institute for Public HealthUniversity of CalgaryCalgaryCanada
  3. 3.Department of Clinical Neurosciences, Cumming School of MedicineUniversity of CalgaryCalgaryCanada
  4. 4.Department of Critical Care Medicine, School of Public Health, Faculty of Medicine and DentistryUniversity of AlbertaEdmontonCanada

Personalised recommendations